等待开盘 02-03 09:30:00 美东时间
+0.110
+1.56%
今日重点评级关注:Benchmark:维持Charter Communications"买入"评级,目标价从425美元升至455美元;BTIG:维持LifeStance Health Gr"买入"评级,目标价从10美元升至11美元
今天 09:06
BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $10 to $11.
02-02 18:53
Drugmakers, hospitals, and health insurers have pumped record sums of funds into lobbying activities in Washington last year as the government continued its efforts to lower healthcare expenditure in ...
01-28 03:21
Despite reporting a mixed Q4 performance, HCA Healthcare (HCA) rose ~7% in the premarket on Tuesday after the nation’s largest for-profit hospital operator announced new share buybacks and boosted its...
01-27 20:59
U.S. stock futures were mostly lower this morning, with the Nasdaq 100 futures ...
2025-12-24 21:06
今日重点评级关注:杰富瑞:维持ImmunityBio Inc Ordinary Shares"买入"评级,目标价从8美元升至9美元;B. Riley证券:维持WAVE Life Sciences"买入"评级,目标价从19美元升至37美元
2025-12-15 15:30
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从12美元升至13美元;Guggenheim:维持Praxis Precision Medicine"买入"评级,目标价从540美元升至760美元
2025-12-10 10:33
Barclays analyst Peter Warendorf initiates coverage on LifeStance Health Gr (NASDAQ:LFST) with a Overweight rating and announces Price Target of $8.
2025-12-09 23:01
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
2025-11-14 10:43
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
2025-11-10 17:17